InvestorsHub Logo
Followers 78
Posts 11422
Boards Moderated 0
Alias Born 04/03/2014

Re: Phoenix300 post# 197

Friday, 03/23/2018 3:49:55 PM

Friday, March 23, 2018 3:49:55 PM

Post# of 427
The space is good - the technology in pre-clinical - 9 to 10 months from starting 1st clinical trial

200 million o/s shares mean - around $75-80 million market cap - higher than one would expect

Unless someone in desperation to enter CNS area goes for BO - this will remain here or lower

Look at TNXP - it has PTSD drug in P3 trial - interim readout in Q3 - still market cap 24 million

That is a good near term gamble compared to this
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMN News